or Try an Advanced Search...

    Recent News for CSCI - COSCIENS Biopharma Inc.

    Date Title
    Nov 15 COSCIENS Biopharma Third Quarter 2024 Earnings: US$1.85 loss per share (vs US$3.41 loss in 3Q 2023)
    Back to the Main CSCI Page...